Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Income" stands at 170.84 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Shionogi & Co. Ltd.'s second quarter result of 44.19 Billion JPY for the item "Net Income" represents an increase of 12.28 percent compared to it's first quarter result.
Also, Shionogi & Co. Ltd.'s second quarter result of 44.19 Billion JPY for the item "Net Income" represents a decrease of -15.83 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s second quarter result of 170.84 Billion JPY for the item "Net Income" represents a decrease of -4.64 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.53 percent compared to the value the year prior.
The 1 year change in percent is 10.53.
The 3 year change in percent is 44.39.
The 5 year change in percent is 41.65.
The 10 year change in percent is 206.52.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income | 280,205,508,085.11 |